You have 9 free searches left this month | for more free features.

Bardoxolone Methyl

Showing 1 - 25 of 438

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Tumors, Pancreatic Cancer Trial in United States (Bardoxolone methyl, Gemcitabine, Placebo)

Terminated
  • Pancreatic Neoplasms
  • Pancreatic Cancer
  • Bardoxolone methyl
  • +2 more
  • Denver, Colorado
  • +4 more
Feb 4, 2022

Diabetic Kidney Disease Trial in Sendai (Bardoxolone methyl, Placebo)

Active, not recruiting
  • Diabetic Kidney Disease
  • Bardoxolone methyl
  • Placebo
  • Sendai, Miyagi, Japan
    Japan Community Health care Organization Sendai Hospital
Jun 26, 2022

Covid19 Trial in United States (Bardoxolone Methyl, Placebo)

Completed
  • Covid19
  • Bardoxolone Methyl
  • Placebo
  • Springfield, Illinois
  • +7 more
Jan 11, 2022

Chronic Kidney Diseases Trial in United States (Bardoxolone methyl oral capsule, Placebo oral capsule)

Completed
  • Chronic Kidney Diseases
  • Bardoxolone methyl oral capsule
  • Placebo oral capsule
  • La Mesa, California
  • +11 more
Feb 28, 2022

IgA Nephropathy, CKD Associated With Type 1 Diabetes, Focal Segmental Glomerulosclerosis Trial in United States (Bardoxolone

Completed
  • IgA Nephropathy
  • +3 more
  • Bardoxolone methyl capsules
  • Birmingham, Alabama
  • +29 more
Mar 15, 2022

Pulmonary Arterial Hypertension, Pulmonary Hypertension, Interstitial Lung Disease Trial in Germany, United States (Bardoxolone

Completed
  • Pulmonary Arterial Hypertension
  • +11 more
  • Bardoxolone methyl
  • Placebo
  • Phoenix, Arizona
  • +31 more
Nov 12, 2021

Alport Syndrome Trial in Worldwide (Placebo Oral Capsule, Bardoxolone Methyl)

Completed
  • Alport Syndrome
  • Placebo Oral Capsule
  • Bardoxolone Methyl
  • Birmingham, Alabama
  • +62 more
Mar 22, 2022

Pulmonary Hypertension Trial in Worldwide (Bardoxolone methyl)

Terminated
  • Pulmonary Hypertension
  • Bardoxolone methyl
  • Phoenix, Arizona
  • +95 more
Mar 22, 2022

Healthy Subject Trial in Osaka (Bardoxolone methyl)

Completed
  • Healthy Subject
  • Bardoxolone methyl
  • Osaka, Japan
    Medical Corporation Heishinkai OPHAC Hospital
Feb 3, 2020

Obese Adult Male Trial in Kurume (Bardoxolone methyl, Placebo)

Completed
  • Obese Adult Male
  • Bardoxolone methyl
  • Placebo
  • Kurume, Fukuoka, Japan
    Applied Bio-Pharmatech Kurume Clinical Pharmacology Clinic
Jun 22, 2020

Connective Tissue Disease-Associated Pulmonary Arterial Hypertension Trial in Worldwide (Placebo capsules, Bardoxolone methyl

Terminated
  • Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
  • Placebo capsules
  • Bardoxolone methyl capsules
  • Phoenix, Arizona
  • +105 more
Apr 29, 2021

Depressive Disorder, MDD, Bipolar Disorder Trial in West Haven (Perampanel 6 MG, Ketamine, Placebo)

Not yet recruiting
  • Depressive Disorder
  • +4 more
  • Perampanel 6 MG
  • +2 more
  • West Haven, Connecticut
    VA Connecticut Healthcare System
Mar 14, 2023

Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors

Recruiting
  • Glioblastoma Multiforme
  • Surgical removal of the GBM tumor
  • d4-NAM infusion
  • Orlando, Florida
    AdventHealth Translational Research Institute
Sep 20, 2023

Local Anesthetic, Ultrasound, Pain, Acute Trial in Cairo (TAPB with dexamethasone as an adjuvant to local anesthetics, TAPB with

Recruiting
  • Local Anesthetic
  • +2 more
  • TAPB with dexamethasone as an adjuvant to local anesthetics
  • TAPB with methylprednisolone as an adjuvant to local anesthetics
  • Cairo, Egypt
    Cairo university hospitals, kasralainy
Nov 9, 2023

Healthy Volunteers Trial in Cincinnati (Bardoxolone methyl capsules 10 mg, Itraconazole capsules 100 mg)

Completed
  • Healthy Volunteers
  • Bardoxolone methyl capsules 10 mg
  • Itraconazole capsules 100 mg
  • Cincinnati, Ohio
    Medpace Clinical Pharmacology Unit
Nov 27, 2017

Preemptive Analgesia, Dexmedetomidine, Ketamine Trial in Kafr Ash Shaykh (Dexmedetomidine, Ketamine, Magnesium sulphate)

Not yet recruiting
  • Preemptive Analgesia
  • +5 more
  • Kafr Ash Shaykh, Karelsheikh, Egypt
    Karelsheikh University Hospital
Apr 19, 2023

Actinic Keratosis, Sun Damaged Skin, Solar Keratosis Trial (Ablative Fractional Carbon Dioxide (CO2) Laser, Microdermabrasion)

Completed
  • Actinic Keratosis
  • +3 more
  • Ablative Fractional Carbon Dioxide (CO2) Laser
  • Microdermabrasion
  • (no location specified)
Sep 13, 2022

Different Doses of Steroids in COVID-19 Patients

Completed
  • Critical Illness
  • Pneumonia, Viral
  • observation for outcome of methylprednisolone dose
  • Cairo, Egypt
  • +1 more
Mar 12, 2022

Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)

Not yet recruiting
  • Depressive Disorder, Major
  • +2 more
  • New Haven, Connecticut
    Yale University
Jun 26, 2023

Polycystic Ovary Syndrome Trial in Hyderabad (laparoscopy / laparotomy, NO INTERVENTION)

Not yet recruiting
  • Polycystic Ovary Syndrome
  • laparoscopy / laparotomy
  • NO INTERVENTION
  • Hyderabad, Telangana, India
    Dr. Shraddha Ramchandani
Oct 25, 2023

Snakebite, Envenoming, Snake Trial (Varespladib intravenous form, varespladib-methyl- oral form, Placebo intravenous form)

Not yet recruiting
  • Snakebite
  • Envenoming, Snake
  • Varespladib intravenous form
  • +3 more
  • (no location specified)
Jan 30, 2023

Multiple Myeloma, Myeloma, Myeloma Multiple Trial in United States (KTX-1001)

Recruiting
  • Multiple Myeloma
  • +2 more
  • Scottsdale, Arizona
  • +5 more
Jan 12, 2023

Schizophrenia Trial in Taichung (NMDAE, Placebo Cap)

Not yet recruiting
  • Schizophrenia
  • Taichung, Taiwan
    Department of Psychiatry, China Medical University Hospital
Sep 4, 2023

Breast Cancer Female Trial (neoadjuvant chemo (AC-T protocol))

Not yet recruiting
  • Breast Cancer Female
  • neoadjuvant chemotherapy (AC-T protocol)
  • (no location specified)
Aug 17, 2022

NSCLC Trial in Shanghai

Not yet recruiting
  • Non-small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Jul 20, 2023